Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
268.00    5.00 (1.90%)
Bid:
269.00
Ask:
270.00
Spread: 1.00 (0.372%)
Market Cap: £240.90m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Directors Dealing

27 Jul 2016 17:21

RNS Number : 4421F
Norcros PLC
27 July 2016
 

27 July 2016

Norcros plc

("Norcros" or "the Company")

 

 Directors' Dealings - APSP Share Option and Deferred Share awards

 APSP Share Option Awards

Norcros announces that the Remuneration Committee of the Company has today granted the following HMRC approved and unapproved share option awards (the "APSP Awards") to the Executive Directors of the Company under the Company's Approved Performance Share Plan (the "APSP") over ordinary shares of ten pence each in the Company ("Ordinary Shares").

Name/Position

Number of Ordinary Shares subject to the APSP Award

Option Exercise Price

Nick Kelsall

Group Chief Executive

232,356 (HMRC unapproved)

Nil

Shaun Smith

Group Finance Director

20,000 (HMRC approved)

150 pence

Shaun Smith

Group Finance Director

136,060 (HMRC unapproved)

Nil

 

Under the APSP, awards are made subject to performance targets relating to the Company's diluted underlying Earnings Per Share ("EPS"). Vesting of these shares is subject to achieving aggregate EPS over a three year performance period, starting with the 2017 financial year.

The APSP Awards will normally vest on the third anniversary of their grant, subject to satisfactory achievement of the performance targets. No consideration was paid for the APSP Awards and the consideration due to be payable on vesting will be the option exercise price (if any) shown above.

Bonus payment - Deferred Share Awards

Under the annual bonus scheme, 50 per cent. of an Executive Director's total bonus for the year is satisfied in cash, with the other 50 per cent. in the form of nil cost options under the Company's Deferred Share Bonus Plan (the "Deferred Plan"). These options represent 50 per cent. of the bonuses earned by the Executive Directors for the 2016 financial year. The previous Group Finance Director's entitlement to this award lapsed on his resignation, effective 12 May 2016.

Norcros therefore also announces that the Remuneration Committee has today granted the following nil cost share option awards in respect of the year ended 31 March 2016 (the "Deferred Awards") to the relevant Executive Director of the Company over ordinary shares of ten pence each in the Company ("Ordinary Shares").

Name/Position

Number of Ordinary Shares subject to the Deferred Plan Award

Nick Kelsall

Group Chief Executive

92,544

 

The Deferred Awards will normally vest on the third anniversary of their grant. Because these shares represent part of a bonus already earned, no consideration was paid for the Deferred Awards and no consideration is due to be payable on vesting.

Other information:

Norcros plc LEI: 213800EIMJZZA1GB1E18

Ordinary Shares identity code: GB00BYYJL418

Date of transaction: 27 July 2016

Place of transaction: Wilmslow, Cheshire, England

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

Shaun Smith, Group Finance Director

 

 

 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

Charlie Jack

 

Katie Cohen

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGURAMUPQGAM
Date   Source Headline
24th Jul 20247:00 amRNSAGM Trading Statement
22nd Jul 20244:06 pmRNSDirector Dealings - APSP Share Option exercises
19th Jul 202410:36 amRNSTotal Voting Rights
2nd Jul 20241:51 pmRNSHolding(s) in Company
1st Jul 202412:53 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSDirector Declaration
21st Jun 20247:00 amRNSAnnual Financial Report and Notice of 2024 AGM
18th Jun 20243:50 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSResults for the year ended 31 March 2024
31st May 20247:00 amRNSTotal Voting Rights
30th May 20244:15 pmRNSHolding(s) in Company
24th May 20247:00 amRNSAppointment of Independent Non-Executive Director
23rd May 20247:30 amRNSDirector Declaration
20th May 20247:00 amRNSSale of Johnson Tiles UK
7th May 20247:00 amRNSNorcros business wins King's Award for Enterprise
1st May 202410:52 amRNSVoting Rights and Share Capital Update
1st May 20247:00 amRNSCapital Markets Event
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.